SEARCH

SEARCH BY CITATION

References

  • 1
    Wintrobe MM & Buell MV. Hyperproteinemia associated with multiple myeloma. Bull John Hopkins Hosp 1933;52:15665.
  • 2
    Lerner AB & Watson CJ. Studies of cryoglobulins. I. Unusual purpura associated with the presence of high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 1947;314:4105.
  • 3
    Meltzer M & Franklin EC. Cryoglobulinemia: a study of 29 patients. I. IgG and IgM cryoglobulins and factors effecting cryoprecipitability. Am J Med 1966;40:82836.
  • 4
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:18792.
  • 5
    Maire MA, Mittey M, Lambert PH. The presence of cryoprecipitable immunoglobulins in normal human sera may reflect specific molecular interactions. Autoimmunity 1989;2:15564.
  • 6
    Martin T, Duffy SF, Carson DA, Kipps TJ. Evidence for somatic selection of natural autoantibodies. J Exp Med 1992;175:98391.
  • 7
    Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:14905.
  • 8
    Dammacco F & Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Immunol 1992;87:3526.
  • 9
    Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974;57:77588.
  • 10
    Musset L, Diemert MC, Taibi F, Thi Houng Du L, Cacoub P, Leger JM et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798802.
  • 11
    Tissot JD, Schifferli JA, Hochstrasser DF, Paquali C, Spertini F, Clement F et al. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J Immunol Meth 1994;173:6375.
  • 12
    Musset L, Duarte F, Gaillard O, Du LT, Bilala J, Galli J et al. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins. Clin Immunol Immunopathol 1994;70:16670.DOI: 10.1006/clin.1994.1025
  • 13
    Abdelmoula M, Spertini F, Shibata T, Gyotoku Y, Luzuy S, Lambert PH et al. IgG3 is the major source of cryoglobulins in mice. J Immunol 1989;143:52632.
  • 14
    Dammacco F & Bonomo L. Crioglobulinemia e piroglobulinemia. In: DammaccoF, editor, Immunologia in Medicina, Edi-Ermes, Milano:1989.p.599.
  • 15
    Geltner D, Franklin EC, Frangione B. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol 1980;125:15305.
  • 16
    Farhangi M & Merlini G. The clinical implications of monoclonal immunoglobulins. Semin Oncol 1986;13:36679.
  • 17
    McFarlane IG. Immunological abnormalities and hepatotropic viral infections. Clin Exp Immunol 1992;87:3379.
  • 18
    Scott DGI, Bacon PA, Elliot PJ, Tribe CR, Wallington TB. Systemic vasculitis in a district general hospital 1972–80: clinical and laboratory features, clarification and prognosis in 80 cases. Q J Med 1982; 203:292311.
  • 19
    Daghestani L & Pomeroy C. Renal manifestations of hepatitis C infection. Am J Med 1999;106:34754.DOI: 10.1016/s0002-9343(99)00014-5
  • 20
    Dammacco F, Sansonno D, Cornacchiulo V, Mennuni C, Carbone R, Lauletta G et al. Hepatitis C virus infection and mixed cryoglobulinemia: a striking association. Int J Clin Lab Res 1993;23:459.
  • 21
    Khella SL, Frost S, Hermann GA, Leventhal L, Whyatt S, Sajid MA et al. Hepatitis C infection, cryoglobulinemia, and vasculitis neuropathy. Treatment with interferon alfa. Case report and review of the literature. Neurology 1995;45:40711.
  • 22
    Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 1983;70:7382.
  • 23
    Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997;25:123744.
  • 24
    Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;297:9467.
  • 25
    Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990;162:56970.
  • 26
    Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumathol 1991;9:6214.
  • 27
    Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, JM Leger et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:12432.
  • 28
    Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:16973.
  • 29
    Dammacco F & Sansonno D. Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 1997;15:97119.
  • 30
    Dammacco F, Gatti P, Sansonno D. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture. Leuk Lymphoma 1998;31:46376.
  • 31
    Sansonno D, Iacobelli AR, Cornacchiulo V, Lauletta G, Di Stasi M, Gatti P et al. Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection. Eur J Clin Invest 1996;26:46575.
  • 32
    Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995;21:30512.
  • 33
    Gorevic PD & Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991;28:7994.
  • 34
    Stewart JJ, Agosto H, Litwin S, Welsh JD, Shomchik M, Weigert M et al. A solution to the rheumatoid factor paradox. Pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors. J Immunol 1997;159:172838.
  • 35
    Carson DA, Chen PP, Kipps TJ. New roles for rheumatoid factor. J Clin Invest 1991;87:37983.
  • 36
    Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 1998;161:13139.
  • 37
    Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996;88:463845.
  • 38
    Mannik MF, Nardella A, Sasso EH. Rheumatoid Factors in Immune Complexes of Patients with Rheumatoid Arthritis. Springer Semin Immunopathol 1988;10:21530.
  • 39
    Monteverde A, Sabattini E, Poggi S, Ballarè M, Bertoncelli MC, De Vivo A et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 1995;20:11924.
  • 40
    Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160:3594601.
  • 41
    Ramos-Casals M, Trejo O, Garcia-Carrasco M, Cervera R, Font J. Mixed cryoglobulinemia: new concepts. Lupus 2000;9:8391.
  • 42
    Tighe H, Warnatz K, Brinson D, Corr M, Weigle WO, Baird SM et al. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc Natl Acad Sci USA 1997;94:64651.DOI: 10.1073/pnas.94.2.646
  • 43
    Kyburz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 1999;163:311622.
  • 44
    De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellino C, Dolcetti R et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997;40:31831.
  • 45
    Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:3924.
  • 46
    Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:304753.
  • 47
    Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996;94:54450.
  • 48
    Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296301.
  • 49
    De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997;55:7782.DOI: 10.1002/(sici)1096-8652(199706)55:2<77::aid-ajh5>3.0.co;2-#
  • 50
    De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997;90:77682.
  • 51
    Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:4238.
  • 52
    Vallisa D, Bertè R, Rocca A, Civardi G, Giangregorio F, Ferrari B et al. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999;106:55660.DOI: 10.1016/s0002-9343(99)00069-8
  • 53
    Ryan J, Wallace S, Jones P, Taggart G, Dudley F. Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol 1994;9:30810.
  • 54
    Borgonovo G, D'Oiron R, Amato A, Leger-Ravet MB, Iseni MC, Smadja C et al. Primary lymphoplasmacytic lymphoma of the liver associated with a serum monoclonal peak of IgG kappa. Am J Gastroenterol 1995;90:13740.
  • 55
    De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:188792.
  • 56
    Satoh T, Yamada T, Nakano S, Tokunaga O, Kuramochi S, Kanai T et al. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection. Cancer 1997;80:19818.DOI: 10.1002/(sici)1097-0142(19971115)80:10<1981::aid-cncr16>3.0.co;2-u
  • 57
    De Vita S, Zagonel V, Russo A, Rupolo M, Cannizzaro M, Chiara G et al. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998;77:20325.
  • 58
    Lombardo L, Rota Scalabrini D, Vineis P, De La Pierre M. Malignant lymphoproliferative disorders in liver cirrhosis. Ann Oncol 1993;4:24550.
  • 59
    Di Stasi M, Sbolli G, Fornari F, Cavanna L, Rossi S, Buscarini E et al. Hepatocellular carcinoma and B-cell tumors. J Hepatol 1994;21:11467.
  • 60
    Clarke G, MacMathuna P, Fenlon H, Callagy G, O'Keane JC, Carney D et al. Primary hepatic lymphoma in a man with chronic hepatitis C. Eur J Gastroenterol Hepatol 1997;9:8790.
  • 61
    Möhler M, Gutzler F, Kallinowsky B, Goeser T, Stremmel W. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection. Dig Dis Sci 1997;42:22415.
  • 62
    Rasul I, Sheperd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999;29:5437.
  • 63
    Viala JJ, Trepo C, Creyssel R, Coiffier B, Rebattu P. Gammapathie monoclonale apparemment non myélomateuse associée à l'antigène de l'hépatite non-A non-B. Nouv Presse Med 1982;11:52.
  • 64
    Heer M, Joller-Jemelka H, Fontana A, Seefeld U, Schmid M, Ammann R. Monoclonal gammopathy in chronic active hepatitis. Liver 1984;4:25563.
  • 65
    Mussini C, Ghini M, Mascia MT, Zanni G, Lattuada I, Giovandari P et al. HCV and monoclonal gammopathies. Clin Exp Rheumatol 1995;13:S459.
  • 66
    Mangia A, Clemente R, Musto P, Cascavilla I, La Floresta P, Sampaolo G. Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. Leukemia 1996;10:120913.
  • 67
    Andreone P, Zignego AL, Cursaro C, Gramenzi A, Gherlinzoni F, Fiorino S et al. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann Intern Med 1998;129:2948.
  • 68
    Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:7516.
  • 69
    Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 1996;77:260413.DOI: 10.1002/(sici)1097-0142(19960615)77:12<2604::aid-cncr26>3.0.co;2-v
  • 70
    Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin Liver Dis 2000;20:15366.
  • 71
    Sansonno D, Lotesoriere C, Cornacchiulo V, Fanelli M, Gatti P, Iodice G et al. Hepatitis C virus infection involves CD34+ hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 1998;92:332837.
  • 72
    Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, O'Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999;29:11938.
  • 73
    McColl MD, Singer IO, Tait RC, McNeil IR, Cumming RL, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkin's lymhoma. A regional association? Leuk Lymphoma 1997;26:12730.
  • 74
    Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999;93:17789.
  • 75
    Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F et al. No association between hepatitis C and B-cell lymphoma. Hepatology 1999;29:125961.
  • 76
    Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987;83:72630.
  • 77
    Casato S, Laganà B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991;78:31427.
  • 78
    Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993;81:11326.
  • 79
    Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Iacobelli AR et al. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994;84:333643.
  • 80
    Sansonno D, Cornacchiulo V, Gatti P, Dammacco F. Circulating levels and liver tissue distribution of intercellular adhesion molecule-1 during beta-interferon therapy of hepatitis C virus-associated chronic active liver disease. Int J Clin Lab Res 1992;22:1005.
  • 81
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C et al. Interferon alpha 2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;92:29834.
  • 82
    Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:837.DOI: 10.1016/s0140-6736(97)06088-1
  • 83
    Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:142632.DOI: 10.1016/s0140-6736(98)07124-4
  • 84
    Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Interferon and ribavirin therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 1998;92:29834.
  • 85
    Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000;27:21728.
  • 86
    Schafer DF & Sorrell MF. Conquering hepatitis C, step by step. N Engl J Med 2000;343:17234.
  • 87
    Cid MC, Hernandez-Rodriguez J, Robert J, Del Rio A, Casademont J, Coll-Vincent B et al. Interferon-alpha may exacerbate cryoglobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity. Arthritis Rheum 1999;42:10515.
  • 88
    Geltner D. Therapeutic Approaches in Mixed Cryoglobulinemia. Springer Semin Immunopatho 1998; 10:10313.
  • 89
    Gallay BJ, Alpers CE, Davis CL, Schultz MF, Johnson RJ. Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995;26:6627.
  • 90
    Brunkhorst R, Klein V, Koch K. Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C. Nephron 1996;72:4657.
  • 91
    Kiyomoto H, Hitomi H, Hosotani Y, Hashimoto M, Uchida K, Kurokouchi K et al. The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection. Ther Apher 1999;3:32933.DOI: 10.1046/j.1526-0968.1999.00196.x
  • 92
    Kaplan AA. Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis. Ther Apher 1997;1:2559.
  • 93
    Suzuki H, Takei T, Tsuji H, Nishikawa T. Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection. Intern Med 2000;39:397400.
  • 94
    Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999; 130:22630.
  • 95
    Lunel F & Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection. J Hepatol 1999; 31:2106.DOI: 10.1016/s0168-8278(99)80215-3
  • 96
    Siami FS & Siami GA. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases. Ther Apher 1997; 1:5862.